Power Law company profile

Tourmaline Bio

Biotech & Life Sciences · New York City, United States · Founded 2022 · IPO 2023 Unicorn

Developing transformative medicines that dramatically improve the lives of patients with life-altering immune diseases

Valuation

$991M

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

16 investors on Tourmaline Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 3 investors entered at this stage

Petrichor

QVT Financial LP

Hydra Ventures

Series A 3 investors entered at this stage

Cowen Healthcare Investments

Deep Track Capital

TCGX

Series B+ 10 investors entered at this stage

Affinity Asset Advisors

StemPoint Capital

KVP Capital

Paradigm BioCapital

Braidwell

Qiming Venture Partners USA

Vivo Capital

Acuta Capital Partners

RA Capital Management

Great Point Partners

Global footprint

Where Tourmaline Bio has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

5.5K monthly visits
across markets

🇺🇸 United States76.4%

🇮🇳 India12.7%

🇨🇦 Canada10.9%

🇧🇪 Belgium0%

Top 4 markets shown

Patent intelligence

$60k patent portfolio · 4 active families

Estimated portfolio value

$60k

<0.01% of market cap · 523.4× smaller than top peer Synthorx ($32M)

4 active patent families

Where Tourmaline Bio innovates InterleukinPharmacologyAntibody fragmentsActive agentPathology

Where Tourmaline Bio concentrates vs peers

Each axis is a top-10 topic across Tourmaline Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Tourmaline Bio

An AI-synthesized read of the highest-engagement posts about Tourmaline Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tourmaline Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles